HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

2009 lux beauty results

This article was originally published in The Rose Sheet

Executive Summary

The prestige beauty segment slipped 6% in the U.S. in 2009 versus prior year, with high-end fragrance representing the greatest drag, according to results presented by the NPD Group at its Jan. 26 "Hot off the Press" event in New York. Sales of prestige fragrances, cosmetics and skin care actually climbed 17% in China, but declined in Mexico (-14%), Spain (-5%), Italy (-4%) and France (-1%). "Make no mistake, 2009 was a most challenging and difficult year for the prestige beauty industry," the market research firm's VP and Senior Beauty Analyst Karen Grant notes. "Yet, particularly as we entered fourth quarter, there was evidence of some recovery as well as areas of growth across categories, at both ends of the price spectrum." Interest in smaller-size women's fragrances, innovative foundation and concealer concepts, anti-aging skin care and hair-care products has picked up, Grant indicates. The food/drug/mass channel recorded flat sales of lux beauty items, with fragrance behind 2008 figures and makeup and skin care (minus hair care) ahead for the year, NPD reports

Latest Headlines
See All
UsernamePublicRestriction

Register

RS016694

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel